Exaggerated claim about adaptive thermogenesis.

Exaggerated claim about adaptive thermogenesis. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Exaggerated claim about adaptive thermogenesis. Abstract Text:

J P Flatt,

Exaggerated claim about adaptive thermogenesis. Publishing Authors By Initials

JP Flatt,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Exaggerated claim about adaptive thermogenesis. Journal Published:

PUBLICATION TYPE: Letter

Journal: International journal of obesity (2005)

VOLUME: 31

Page Numbers: 1626; author reply 1627-8

Journal Abbreviation:

ISSN: 0307-0565

DAY: 29

MONTH: 05

YEAR: 2007

Exaggerated claim about adaptive thermogenesis. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 101256108

Exaggerated claim about adaptive thermogenesis. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Exaggerated claim about adaptive thermogenesis. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Exaggerated claim about adaptive thermogenesis.

AFFILIATION:

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Int J Obes (Lond)

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Exaggerated claim about adaptive thermogenesis Related Publications

• Adrian Ede Flatt, MD, FRCS: a conversation with the editor. Interview by William Clifford Roberts.
• Antidiabetic effects of sub-chronic administration of the cannabinoid receptor (CB(1)) antagonist, AM251, in obese diabetic (ob/ob) mice.
• Bribery in the anaesthetic room.
• C-terminal mini-PEGylation of glucose-dependent insulinotropic polypeptide exhibits metabolic stability and improved glucose homeostasis in dietary-induced diabetes.
• Chemical gastric inhibitory polypeptide receptor antagonism protects against obesity, insulin resistance, glucose intolerance and associated disturbances in mice fed high-fat and cafeteria diets.
• Comparison of independent and combined chronic metabolic effects of GIP and CB(1) receptor blockade in high-fat fed mice.
• Comparison of the anti-diabetic effects of GIP- and GLP-1-receptor activation in obese diabetic (ob/ob) mice: studies with DPP IV resistant N-AcGIP and exendin(1-39)amide.
• Comparison of the metabolic effects of GIP receptor antagonism and PYY(3-36) receptor activation in high fat fed mice.
• Daily administration of the GIP-R antagonist (Pro3)GIP in streptozotocin-induced diabetes suggests that insulin-dependent mechanisms are critical to anti-obesity-diabetes actions of (Pro3)GIP.
• Decreased dipeptidyl peptidase-IV activity and glucagon-like peptide-1(7-36)amide degradation in type 2 diabetic subjects.
• Differences in Basal energy expenditure and obesity.
• Effects of gastric inhibitory polypeptide (GIP) and related analogues on glucagon release at normo- and hyperglycaemia in Wistar rats and isolated islets.
• Exaggerated claim about adaptive thermogenesis.
• GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet.
• Grasp.
• Incretin hormone mimetics and analogues in diabetes therapeutics.
• Interactions between energy and protein metabolism in man.
• Iterative exposure of clonal BRIN-BD11 cells to ninhydrin enables selection of robust toxin-resistant cells but with decreased gene expression of insulin secretory function.
• Minor hand injuries.
• Notta's nodules and trigger digits.
• Our thumbs.
• Reclamation of the rheumatoid hand.
• Streptozotocin-resistant BRIN-BD11 cells possess wide spectrum of toxin tolerance and enhanced insulin-secretory capacity.
• Surgical restoration of the hand in epidermolysis bullosa.
• The Vikings and Baron Dupuytren's disease.
• The development of a turbine-driven circulating blower for manned aerospace enclosures. AMRL-TR-67-126.
• The development of gas and liquid circulating devices for manned space enclosures. AMRL-TR-65-128.
• The thenar flap.
• The truth about trauma care.
• Webbed fingers.